News

The global c-reactive protein testing market size is expected to be worth around US$ 10.6 billion by 2030, according to a new report by Vision Research Reports.

The global c-reactive protein testing market size was valued at US$ 8.5 billion in 2020 and is anticipated to grow at a CAGR of 0.6% during forecast period 2021 to 2030.

Get Sample Copy of This Report@https://www.visionresearchreports.com/report/sample/38686

Report Coverage

Report Scope	Details
Market Size	USD 10.6 billion by 2030
Growth Rate	CAGR of 0.6% From 2021 to 2030
Base Year	2021
Forecast Period	2021 to 2030
Segments Covered	Assay type, Detection range, Disease type, End-use
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned	Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche Ltd; Danaher; Quest Diagnostics; Siemens Healthineers AG; Abbott; Merck KGaAA; Zoetis; Ortho Clinical Diagnostics; Getein Biotech, Inc; HORIBA, Ltd; Randox Laboratories Ltd; BODITECH MED, INC.; Aidian

Growth Factors

 The market growth can be attributed to substantial research activities to explore the applications of C-reactive protein (CRP) testing coupled with the presence of private as well as public agencies which grant funds to expedite the research proceedings in this arena.

A rise in the number of strategic deals and developments coupled with the increase in investments for R&D of C-reactive protein testing is expected to drive the market significantly. The ongoing COVID-19 pandemic has affected the CRP testing market to a great extent. As CRP is considered to be the determining biomarker for the severity of infection/inflammation, the market is witnessing increased demand for CRP testing services and products. Major operating companies such as Abbott offer supportive tools for CRP testing for SARS-CoV-2 infection.

Key Players

• Thermo Fisher Scientific, inc.
• F. Hoffmann-La Roche Ltd.
• Danaher
• Quest Diagnostics
• Siemens Healthineers AG
• Abbott
• Merck KGaAA
• Zoetis
• Ortho Clinical Diagnostics
• Getein Biotech, Inc.
• HORIBA, Ltd
• Randox Laboratories Ltd.
• BODITECH MED, INC.
• Aidian

Market Segmentation

• Assay Type
  • Immunoturbidimetric Assay
  • ELISA
    • Clinical
    • Non-clinical
  • Chemiluminescence Immunoassay
  • Others
• Detection Range
  • hs-CRP
  • Conventional CRP
  • cCRP
• Disease Area
  • Cardiovascular Diseases
  • Cancer
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others
• End-use
  • Clinics
    • By Entity
      • Physician Offices
      • Small Clinics
      • Others
    • By Settings
      • Urban Setting
      • Rural Setting
  • Hospitals
    • Urban Setting
    • Rural Setting
  • Laboratories
    • Urban Setting
    • Rural Setting
  • Assisted Living Healthcare Facilities
    • Urban Setting
    • Rural Setting
  • Home
  • Others
• Regional
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
  • Middle East and Africa (MEA)
    • South Africa

Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38686 or call: +1 9197 992 333